Clinical trial
Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease
NCT00130429 · Phytopharm, Industry · Completed
Key facts
| NCT number | NCT00130429 |
|---|---|
| Title | Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease |
| Official title | Phase II Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Effect on Cognition and Pharmacokinetic Profile of PYM50028 in Subjects With Mild Dementia of the Alzheimer's Type |
| Lead sponsor | Phytopharm, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | PYM50028 |
| Enrollment | 250 |
| Start date | Jan 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Aug 15, 2005 |
| Last update posted | Aug 21, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: